[1]
“Exploring the Expanded Therapeutic Landscape of SGLT2 Inhibitors: Beyond Diabetes Management”, Bangla J Med, vol. 35, no. 20, p. 143, Jun. 2024, doi: 10.3329/bjm.v35i20.73403.